Lazard Asset Management’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24
| Closed | – | – | 2312 |
|
|
2024
Q4 | $0 | Sell |
24
-54,551
| -100% | – | ﹤0.01% | 2291 |
|
|
2024
Q3 | $1.34M | Buy |
54,575
+7,659
| +16% | +$188K | ﹤0.01% | 990 |
|
|
2024
Q2 | $1.1M | Sell |
46,916
-8,177
| -15% | -$191K | ﹤0.01% | 956 |
|
|
2024
Q1 | $1.82M | Sell |
55,093
-3,413
| -6% | -$113K | ﹤0.01% | 840 |
|
|
2023
Q4 | $1.59M | Sell |
58,506
-2,284
| -4% | -$62.1K | ﹤0.01% | 889 |
|
|
2023
Q3 | $1.46M | Sell |
60,790
-1,700
| -3% | -$40.9K | ﹤0.01% | 911 |
|
|
2023
Q2 | $2M | Sell |
62,490
-15
| -0% | -$479 | ﹤0.01% | 889 |
|
|
2023
Q1 | $1.91M | Buy |
62,505
+816
| +1% | +$25K | ﹤0.01% | 917 |
|
|
2022
Q4 | $2.41M | Sell |
61,689
-52,163
| -46% | -$2.04M | ﹤0.01% | 880 |
|
|
2022
Q3 | $5.42M | Buy |
113,852
+5,820
| +5% | +$277K | 0.01% | 690 |
|
|
2022
Q2 | $4.18M | Buy |
108,032
+37,182
| +52% | +$1.44M | 0.01% | 767 |
|
|
2022
Q1 | $4.06M | Buy |
70,850
+17,722
| +33% | +$1.02M | ﹤0.01% | 789 |
|
|
2021
Q4 | $4.23M | Buy |
53,128
+27,322
| +106% | +$2.18M | ﹤0.01% | 803 |
|
|
2021
Q3 | $2.25M | Buy |
25,806
+1,215
| +5% | +$106K | ﹤0.01% | 896 |
|
|
2021
Q2 | $3.17M | Buy |
24,591
+24,210
| +6,354% | +$3.12M | ﹤0.01% | 792 |
|
|
2021
Q1 | $30K | Buy |
+381
| New | +$30K | ﹤0.01% | 1642 |
|